Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
Top Cited Papers
Open Access
- 21 January 2025
- journal article
- review article
- Published by MDPI AG in Nanomaterials
- Vol. 15 (3) , 158
Abstract
Active cancer targeting consists of the selective recognition of overexpressed biomarkers on cancer cell surfaces or within the tumor microenvironment, enabled by ligands conjugated to drug carriers. Nanoparticle (NP)-based systems are highly relevant for such an approach due to their large surface area which is amenable to a variety of chemical modifications. Over the past decades, several studies have debated the efficiency of passive targeting, highlighting active targeting as a more specific and selective approach. The choice of conjugation chemistry for attaching ligands to nanocarriers is critical to ensure a stable and robust system. Among the panel of cancer biomarkers, the epidermal growth factor receptor (EGFR) stands as one of the most frequently overexpressed receptors in different cancer types. The design and development of nanocarriers with surface-bound anti-EGFR ligands are vital for targeted therapy, relying on their facilitated capture by EGFR-overexpressing tumor cells and enabling receptor-mediated endocytosis to improve drug accumulation within the tumor microenvironment. In this review, we examine several examples of the most recent and significant anti-EGFR nanocarriers and explore the various conjugation strategies for NP functionalization with anti-EGFR biomolecules and small molecular ligands. In addition, we also describe some of the most common characterization techniques to confirm and analyze the conjugation patterns.Keywords
Funding Information
- Swiss National Science Foundation (200021E_205745)
This publication has 365 references indexed in Scilit:
- Simultaneous blockade of the CD73/EGFR axis inhibits tumor growthIUBMB Life, 2025
- Genetically Engineered Cell Membrane‐Coated Magnetic Nanoparticles for High‐Performance Isolation of Circulating Tumor CellsAdvanced Functional Materials, 2023
- Dynamic responsiveness of self‐assembling peptide‐based nano‐drug systemsInterdisciplinary Medicine, 2023
- Optimal Physicochemical Properties of Antibody–Nanoparticle Conjugates for Improved Tumor TargetingAdvanced Materials, 2022
- EGF‐functionalized lipid–polymer hybrid nanoparticles of 5‐fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinomaBiotechnology and Applied Biochemistry, 2021
- Epidermal growth factor receptor (EGFR) involvement in epithelial‐derived cancers and its current antibody‐based immunotherapiesCell Biology International, 2020
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growthInternational Journal of Cancer, 2011
- Chemical Synthesis of Triple‐Labelled Three‐Helix Bundle Binding Proteins for Specific Fluorescent Detection of Unlabelled ProteinChemBioChem, 2005
- Click Chemistry: Diverse Chemical Function from a Few Good ReactionsAngewandte Chemie International Edition, 2001